| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |